Diabetech - Diabetes Tech, Research, News

ADA 2026 Scientific Sessions brought a wave of exciting diabetes technology announcements, and Endo Dr. David Ahn and I dig into all of it in a live recording of the podcast! From a hands-on look at the new MiniMed Flex to updates from Tandem, Omnipod, twiist, and the open-source community, our discussion explores how these innovations could shape the future of diabetes care. We also dive into Abbott’s new dual glucose-ketone...

Commercial airline pilot John Roth shares how his diagnosis grounded him in 2015 and forced him to step away from the cockpit. Through years of advocacy, legal challenges, and advances in diabetes technology, John helped pave the way for pilots with type 1 diabetes to regain their right to fly. The conversation explores the emotional toll of losing a passion, the role CGMs played in changing FAA policy, and the strict medical requi...

I sat down with MiniMed's CTO to explore the new app-controlled pump, the MiniMed Flex and walk through its redesigned app ecosystem. We also discussed the next-generation Vivera algorithm, designed to reduce or potentially eliminate the need for meal boluses while improving time in range for users. And in a surprise reveal, MiniMed gave us an early look at the upcoming tubeless patch pump called "MiniMed Fit", sharing details abou...

Katie Beth Hand, patient 9 in the Eledon trial, received an islet cell transplant in January 2026. She is now living a "functionally cured" life, but every 21 days she requires a transfusion of an immunosuppressant called Tegoprubart which stops her body from attacking the newly implanted islet cells. In this conversation, we get into how the trial works, what it feels like to stop taking insulin after years of type 1 diabetes, and...

Dexcom has heard the community's concerns around sensor accuracy, connectivity, adhesive performance, and transparency. In this episode, I sit down with Dexcom CEO Jacob Leach and CTO Peter Simpson to discuss how the company is addressing those concerns, improving the Dexcom G7, and working to rebuild trust with users. We also get an exclusive look at the future of Dexcom, including enhanced algorithms, improved reliability, the up...

Sending a child to school with type 1 diabetes should be easier in 2026. In this episode I break down why it remains one of the most stressful parts of managing the disease. I sit down with Dr. Taylor Inman, a physician and parent of a child with type 1 diabetes, to unpack the major gaps in school-based diabetes care despite widespread use of CGMs and insulin pumps. We explore how outdated policies, lack of training, and limited su...

We break down why exercise can be one of the most challenging parts of living with type 1 diabetes. We dive into how different types of workouts affect blood sugar, how to prevent highs and lows during exercise, and how to use insulin pumps, CGMs, and diabetes technology more effectively while staying active. Gary shares practical strategies for adjusting insulin, timing carbs, using exercise mode, and preparing for cardio, weightl...

I’m joined by Cory Zapatka, the developer of the Stash app. We dive into how the app works—from barcode scanning and inventory tracking to recall alerts, a trip planner, and an infusion site tracker—and how it can simplify the day-to-day chaos of diabetes management. Cory also shares how he built the app without a traditional coding background using AI tools, and what that says about the future of building in diab...

Continuous glucose monitors (CGMs) play a major role in diabetes management, but not all CGM accuracy and testing standards are the same. In this episode, I sit down with John Pemberton of Glucose Never Lies to break down how CGMs are tested, and why FDA clearance and CE marking aren’t equivalent when it comes to insulin dosing safety. As diabetes technology moves toward automated insulin delivery, we explore the risks of rel...

I share my unfiltered review of the twiist insulin pump, diving deeper into my personal experience after two months of real-world use. I go beyond a standard review to break down how features like Apple Watch control, glycemic index-based carb logging, and retroactive carb adjustments performed in my day-to-day life. I also get the highs and lows, from strong glucose control and 87% time in range to frustrations with the Cleo infus...

Gary Scheiner, CDCES, and I break down why hypoglycemia (low blood sugar) is one of the most dangerous and frustrating parts of living with diabetes. We dive into how to prevent low blood sugar, reduce the frequency and severity of hypos, and avoid rebound highs using insulin pumps, CGMs, and smarter insulin timing. Gary shares practical strategies for adjusting settings, treating lows without overcorrecting, and using diabetes tec...

I sit down with Allan Coukell, Civica's Chief of Government Affairs & Public Policy Officer, to explore how its nonprofit insulin model and California’s CalRx partnership are bringing low-cost insulin—priced around $11 per pen and $30 per vial—to people nationwide, with or without insurance. We break down how pharmacy benefit managers, rebates, and the current drug pricing system have kept insulin prices high,...

I sat down with Dr. Monica Gomberg and Sherry Roberts from Blue Circle Health to explore how they’re redefining care for adults living with type 1 diabetes. We break down the real gaps in our healthcare system—from insurance battles and financial barriers to diabetes distress—and how this free, nationwide program helps people access endocrinology care, certified diabetes education, CGMs, and even direct financial ...

I spoke with leaders from Senseonics and Sequel MedTech to unpack a major first in diabetes tech—the integration of the Eversense 365 implantable continuous glucose monitor with the twiist insulin pump for automated insulin delivery. We explore how this implantable CGM works, what makes it different from traditional sensors, and how the new looping system connects through dual apps to support a more automated diabetes managem...

Gary Scheiner, CDCES, and I break down how to improve mealtime insulin dosing and why boluses still matter even with automated insulin delivery systems. We talk through insulin-to-carb ratios, pre-bolus timing, extended boluses, and how different foods impact post-meal blood sugar patterns. Gary shares practical ways to read your CGM data to tell whether highs and lows are caused by timing, dosing, or carb counting challe...

I spoke with endocrinologist and diabetes tech expert Dr. David Ahn at the ATTD conference about the biggest breakthroughs shaping the future of diabetes management, including the rapid progress toward fully closed-loop insulin delivery systems. We explored how companies like MiniMed, CamAPS, and Omnipod are advancing automation that reduces carb counting, minimizes manual bolusing, and improves time-in-range outcomes. We also disc...

I spoke with journalist and cure expert Ginger Vieira to unpack major developments including stem-cell therapies, donor islet cell transplants, and the growing debate around the Islet Cell Act currently stalled in U.S. Congress. We examine why promising results from trials like Eledon's still face challenges around safety, scalability, and immunosuppression despite exciting early outcomes and break down the latest breakthroughs in ...

I sit down with Hanne Engan to discuss her experience being detained by ICE during what was supposed to be a routine U.S. green card interview. We unpack how immigration enforcement policies intersected with a life-threatening medical crisis when Hana—who has type 1 diabetes—was denied critical insulin and medical care inside an immigration detention center. Through her firsthand account, we explore the realities of vis...

Gary and I break down why insulin doesn’t always work the way we expect—whether it’s absorption issues, site problems, heat exposure, stress, hormones, illness, or exercise. We talk about how automated insulin delivery systems are only as good as the insulin actually getting into your body, and why fixing efficacy often matters more than changing your settings. Gary shares practical strategies for improving absorp...